Works about VALSARTAN
Results: 789
Effectiveness of Valsartan's Single-Pill Combination Therapies on Blood Pressure Control in Hypertensive Patients: Malaysian Single-Centre Real-World Experience.
- Published in:
- Malaysian Journal of Medical Sciences, 2023, v. 30, n. 5, p. 116, doi. 10.21315/mjms2023.30.5.10
- By:
- Publication type:
- Article
Impact of clinical pharmacy guidance on valsartan recall management: a retrospective review.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 6, p. 278, doi. 10.1007/s40267-022-00918-6
- By:
- Publication type:
- Article
Saturated Bioisosteres of ortho‐Substituted Benzenes.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 46, p. 20696, doi. 10.1002/ange.202004183
- By:
- Publication type:
- Article
Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 505, doi. 10.1007/s10557-022-07421-0
- By:
- Publication type:
- Article
Sacubitril/Valsartan Can Reduce Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 3, p. 549, doi. 10.1007/s10557-022-07315-1
- By:
- Publication type:
- Article
Five Years of Sacubitril/Valsartan—a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 915, doi. 10.1007/s10557-021-07210-1
- By:
- Publication type:
- Article
The Effect of Valsartan versus Non-RAAS Treatment on Autoregulation of Cerebral Blood Flow.
- Published in:
- Cerebrovascular Diseases, 2012, v. 34, n. 1, p. 78, doi. 10.1159/000338777
- By:
- Publication type:
- Article
The Effect of Valsartan versus Non-RAAS Treatment on Autoregulation of Cerebral Blood Flow.
- Published in:
- Cerebrovascular Diseases, 2012, v. 34, n. 1, p. 78, doi. 10.1159/000338777
- By:
- Publication type:
- Article
Strength-Dependent and Strength-Independent Dissolution Patterns of Poorly-Soluble Drugs. Case Example: Valsartan.
- Published in:
- Pharmaceutical Chemistry Journal, 2021, v. 54, n. 12, p. 1227, doi. 10.1007/s11094-021-02347-7
- By:
- Publication type:
- Article
Comparison of Approaches to Determining N-Nitrosodimethylamine Impurity in Valsartan Drug Substance By GC-MS Methods.
- Published in:
- Pharmaceutical Chemistry Journal, 2019, v. 53, n. 8, p. 766, doi. 10.1007/s11094-019-02076-y
- By:
- Publication type:
- Article
Could ARNI have an Effect on LV Fibrosis and Inflammatory Parameters in an Experimental Autoimmune Myocarditis Model?
- Published in:
- Eurasian Journal of Medical Investigation, 2022, v. 6, n. 2, p. 190, doi. 10.14744/ejmi.2022.80484
- By:
- Publication type:
- Article
Spectrophotometric determination of Valsartan in pure form and in its pharmaceutical preparations.
- Published in:
- Al-Qadisiyah Journal of Pure Science, 2021, v. 26, n. 4, p. 239, doi. 10.29350/qjps.2021.26.4.1317
- By:
- Publication type:
- Article
Effects of Valsartan vs Amlodipin on renal function in salt loaded spontaneously hypertensive rats.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2014, v. 60, n. 1, p. 53, doi. 10.33320/maced.pharm.bull.2014.60.01.007
- By:
- Publication type:
- Article
PROTECTIVE EFFECTS OF AT1-RECEPTOR BLOCKER AND CA ANTAGONIST COMBINATION ON RENAL FUNCTION IN SALT LOADED SPONTANEOUSLY HYPERTENSIVE RATS.
- Published in:
- Contributions / Prilozi (1857-9345), 2015, v. 36, n. 1, p. 85, doi. 10.1515/prilozi-2015-0033
- By:
- Publication type:
- Article
Effects of Ramipril and Valsartan on Proteinuria and Renal Function in Patients with Nondiabetic Proteinuria.
- Published in:
- Collegium Antropologicum, 2011, v. 35, n. 4, p. 1061
- By:
- Publication type:
- Article
EFFICACY OF VALSARTAN PLUS AMLODIPINE VERSUS VALSARTAN PLUS HYDROCHLOROTHIAZIDE FOR CONTROL OF MODERATE TO SEVERE HYPERTENSION: A RANDOMIZED CONTROLLED TRIAL.
- Published in:
- Pakistan Heart Journal, 2017, v. 50, n. 1, p. 39
- By:
- Publication type:
- Article
Understanding the molecular-pharmaceutical basis of sartan recalls focusing on valsartan.
- Published in:
- Global Cardiology Science & Practice, 2020, v. 2020, n. 2, p. 1, doi. 10.21542/gcsp.2020.25
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan in patients with left ventricular assist devices: Case series.
- Published in:
- Artificial Organs, 2021, v. 45, n. 2, p. 185, doi. 10.1111/aor.13796
- By:
- Publication type:
- Article
A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS).
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-79272-8
- By:
- Publication type:
- Article
Subgroup disproportionality analysis of dementia-related adverse events with sacubitril/valsartan across geographical regions.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67050-5
- By:
- Publication type:
- Article
Initiation, treatment response evaluation, and safety monitoring of angiotensin receptor/neprilysin inhibitors (Sacubitril/Valsartan) in the management of heart failure in India: An expert group recommendations.
- Published in:
- Journal of Indian College of Cardiology, 2023, v. 13, n. 4, p. 141, doi. 10.4103/jicc.jicc_22_23
- By:
- Publication type:
- Article
Photocatalytic Degradation of Valsartan by MoS 2 /BiOCl Heterojunctions.
- Published in:
- Catalysts (2073-4344), 2021, v. 11, n. 6, p. 650, doi. 10.3390/catal11060650
- By:
- Publication type:
- Article
Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.
- Published in:
- Diabetic Medicine, 2009, v. 26, n. 12, p. 1204, doi. 10.1111/j.1464-5491.2009.02864.x
- By:
- Publication type:
- Article
Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
- Published in:
- Nephrology, 2015, v. 20, n. 2, p. 77, doi. 10.1111/nep.12359
- By:
- Publication type:
- Article
Probucol combined with valsartan in immunoglobulin A nephropathy: A multi-centre, open labelled, randomized controlled study.
- Published in:
- Nephrology, 2014, v. 19, n. 1, p. 40, doi. 10.1111/nep.12177
- By:
- Publication type:
- Article
Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.
- Published in:
- Nephrology, 2011, v. 16, n. 5, p. 502, doi. 10.1111/j.1440-1797.2011.01448.x
- By:
- Publication type:
- Article
Co-inhibition of Angiotensin II Receptor and Endothelin-1 Attenuates Renal Injury in Unilateral Ureteral Obstructed Mice.
- Published in:
- Kidney & Blood Pressure Research, 2016, v. 41, n. 4, p. 450, doi. 10.1159/000443446
- By:
- Publication type:
- Article
Effects of Renin-Angiotensin System Inhibitors on Renal Expression of Renalase in Sprague-Dawley Rats Fed With High Salt Diet.
- Published in:
- Kidney & Blood Pressure Research, 2015, v. 40, n. 6, p. 605, doi. 10.1159/000368536
- By:
- Publication type:
- Article
Role of Fosinopril and Valsartan on Klotho Gene Expression Induced by Angiotensin II in Rat Renal Tubular Epithelial Cells.
- Published in:
- Kidney & Blood Pressure Research, 2010, v. 33, n. 3, p. 186, doi. 10.1159/000316703
- By:
- Publication type:
- Article
Roselle (Hibiscus sabdariffa L.) extract as an adjunct to valsartan in patients with mild chronic kidney disease: A double-blind randomized controlled clinical trial.
- Published in:
- Avicenna Journal of Phytomedicine, 2024, v. 14, n. 4, p. 505, doi. 10.22038/AJP.2024.23871
- By:
- Publication type:
- Article
Cost Effectiveness of the First‐in‐Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1187, doi. 10.1007/s40273-022-01182-2
- By:
- Publication type:
- Article
Preparation, characterization, and in vivo evaluation of valsartan porous matrices using emulsion solvent evaporation technique.
- Published in:
- International Journal of Pharmaceutical Investigation, 2016, v. 6, n. 3, p. 169, doi. 10.4103/2230-973X.187345
- By:
- Publication type:
- Article
A REVIEW ON ANALYTICAL METHODS FOR INDIVIDUAL AND SIMULTANEOUS ANALYSIS OF ALISKIREN AND VALSARTAN.
- Published in:
- Pharma Science Monitor, 2023, v. 14, n. 2, p. 23
- By:
- Publication type:
- Article
FORMULATION & DEVELOPMENT OF LAMOTRIGINE LOADED LIQUISOLID OROODISPERSIBLE TABLETS USING DoE APPROACH.
- Published in:
- Pharma Science Monitor, 2022, v. 13, n. 1, p. 23
- By:
- Publication type:
- Article
FORMULATION, DEVELOPMENT AND CHARACTERIZATION OF SUSTAINED RELEASE BILAYERED TABLET OF VALSARTAN AND PIOGLITAZONE HCl.
- Published in:
- Pharma Science Monitor, 2013, v. 4, n. 3, p. 311
- By:
- Publication type:
- Article
FORMULATION AND EVALUATION OF TRANSDERMAL PATCH OF AN ANTIHYPERTENSIVE DRUG.
- Published in:
- Pharma Science Monitor, 2013, v. 4, n. 1, p. 3664
- By:
- Publication type:
- Article
Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction Spectrum.
- Published in:
- Frontiers in Physiology, 2021, v. 12, p. 1, doi. 10.3389/fphys.2021.652163
- By:
- Publication type:
- Article
A Simple Score to Identify Super-Responders to Sacubitril/Valsartan in Ambulatory Patients With Heart Failure.
- Published in:
- Frontiers in Physiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphys.2021.642117
- By:
- Publication type:
- Article
Understanding the dosing-time-dependent antihypertensive effect of valsartan and aspirin through mathematical modeling.
- Published in:
- Frontiers in Endocrinology, 2023, v. 14, p. 01, doi. 10.3389/fendo.2023.1110459
- By:
- Publication type:
- Article
Paraoxonase Activity and Expression Is Modulated by Therapeutics in Experimental Rat Nonalcoholic Fatty Liver Disease.
- Published in:
- International Journal of Hepatology, 2012, p. 1, doi. 10.1155/2012/265305
- By:
- Publication type:
- Article
Design and physico-mechanical evaluation of fast-dissolving valsartan polymeric drug delivery system by electrospinning method.
- Published in:
- Iranian Journal of Basic Medical Sciences, 2021, v. 24, n. 12, p. 1683, doi. 10.22038/IJBMS.2021.58713.13041
- By:
- Publication type:
- Article
Sacubitril/Valsartan (Entresto) for Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 314, n. 7, p. 722, doi. 10.1001/jama.2015.9398
- Publication type:
- Article
Heart Failure Drug Gains Approval.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 314, n. 7, p. 662, doi. 10.1001/jama.2015.9770
- By:
- Publication type:
- Article
Clinical Trial Results May Lead to Changes in Cardiovascular Care.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 19, p. 1957, doi. 10.1001/jama.2014.14319
- By:
- Publication type:
- Article
The U.S. Medicine Chest: Implications of Increased Reliance on China.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparison of the effects of giving captopril and valsartan in cases of heart failure for people with congenital heart disease.
- Published in:
- EurAsian Journal of Biosciences, 2020, v. 14, n. 2, p. 3463
- By:
- Publication type:
- Article
Topikalni steroidi i CO<sub>2</sub>-laser u terapiji refraktorne lihenoidne reakcije na lijekove i lihenoidne kontaktne lezije: prikaz slučaja.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Acute pancreatitis associated with lisinopril and olanzapine.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
New drugs and dosage forms.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. 21, p. 1890
- Publication type:
- Article
Valsartan Improves β-Cell Function and Insulin Sensitivity in Subjects With Impaired Glucose Metabolism.
- Published in:
- Diabetes Care, 2011, v. 34, n. 4, p. 845, doi. 10.2337/dc10-2224
- By:
- Publication type:
- Article